PTC BRIDGE™
Origin language: English
Country
Kenya
Rwanda
Malawi
South Africa
Nigeria
Namibia
Mozambique
Malaysia
Indonesia
Botswana
Coverage
International
Nb of implementation sites
4
Lead organization
Implementation partners
Health Focus Area
Medications/Pharmacy
Communicable diseases
Cancer
Vaccination / Immunization
Services
Health Management Information Systems (HMIS)
Predictive health and early diagnosis
Electronic medical record
Enabling technologies
Internet of Things
Big Data Analytics
Phone
Blockchain
Software
Standards
EDA - Aggregated Data Exchange
Excel
ICD-10
BPPC - Basic Patient Privacy Consents
PII
Tools
Funding sources
Private funds
Business model
Data monetization
Usage fee / pay per use
Freemium
Funders
N/A
Summary
PTC BRIDGE delivers a powerful, offline-first middleware solution designed to swiftly digitize clinical trial sites in Africa and Asia, facilitating the transition from paper-based records to GCP-compliant eSource and EDC-integrated workflows within 90 days. Key features include 2G-optimized offline queuing, AI-driven patient pre-screening, and WhatsApp-based eConsent, empowering trial site directors to lessen recruitment delays, reduce screen failures, and boost site readiness. This innovative approach enables quicker feasibility responses and strengthens connections with sponsors in resource-limited settings. The health focus areas for PTC BRIDGE cover Cancer, Communicable diseases, Medications/Pharmacy, and Vaccination/Immunization, targeting a diverse population that includes adults (18+), health professionals, and individuals in both rural and urban communities.
Keywords
Big data
Clinical data management
Data aggregation
Digitally enabled integrated care approaches
Mobile application
Publications
Insights - Lessons learnt
Challenges
Implementing PTC BRIDGE in clinical trial sites across Africa and Asia has highlighted several hurdles common to digital transformation in resource-limited settings. Process-related challenges include resistance to change among site staff accustomed to paper-based workflows, leading to slower adoption during initial training phases. Technical issues involve intermittent connectivity in rural areas, despite our offline-first design, and the complexity of mapping diverse legacy paper records to OMOP standards, which can extend digitization timelines. Contextual factors, such as varying regulatory requirements across countries (e.g., NAFDAC in Nigeria and BPOM in Indonesia), have occasionally delayed onboarding. Additionally, economic constraints at some sites have influenced prioritization of immediate operational needs over long-term digitization.
Resistance to change
Internet access
Infrastructure availability
Policy, regulatory and compliance barriers
Operational cost and maintenance
Recommendations
Positive Influences on Implementation. Several factors have facilitated success. Strong involvement from key stakeholders, including principal investigators and site directors at pilot locations like Ashmed Medical Centre in South Africa and our new CRO partner in Indonesia, has driven enthusiasm and buy-in. The FDA's FDORA diversity requirements, effective July 2025, have created urgency among sponsors for underrepresented cohorts, aligning perfectly with our focus on African and Asian patient populations and accelerating site interest in rapid digitization. Recommendations and Best Practices - Best practices identified include partnering early with local CROs for regulatory navigation, using performance-based pilot agreements to build trust, and leveraging OMOP/CDISC mapping from day one for submission-ready data. Implications - For policy and practice, PTC BRIDGE underscores the need for supportive frameworks that incentivize site digitization in emerging markets, potentially informing global guidelines on diverse trial inclusion. Technically, our offline-first approach offers a scalable model for low-bandwidth environments. Research implications include opportunities to study long-term impacts on enrollment efficiency and diversity. Overall, these insights point to strong sustainability through recurring site subscriptions and sponsor partnerships, positioning PTC BRIDGE for scalable growth while maintaining patient access as free forever. If you are navigating similar challenges at your site, I'd be happy to discuss tailored strategies.
Recommendations
Projects using similar services
Projects focusing on similar topics
Projects with similar insights
Any additional questions?
iDHA (Project ID)
estnr6
Project links
https://pharmatrialconnect.com/bridgeOrigin of information
Project stakeholder
Data source link
N/AAdded to the platform on
2025-12-15
Project editors
Last update by
Tonie Konig on 2025-12-15
Number of views
95
WHO classifications




